Hi-Tech Pharmacal Co. will make an investor presentation Tuesday during the Bank of America's 2011 Health Care Conference in Las Vegas.
The Amityville generic drug maker, which specializes in liquid and semi-solid doses, will carry a live audio webcast of the company's presentation on its website. The webcast will be archived within an hour after the live event and will be available for 16 days.
Hi-Tech makes and markets generic, prescription, over-the-counter and nutritional products for asthma, bronchial disorders, dermatological disorders, allergies, pain, stomach, oral care, neurological disorders, glaucoma, and other conditions. The company's generic pharmaceutical products include oral solutions and suspensions, topical creams and ointments, and nasal sprays.
Headed by chief executive David S. Seltzer, 51, the company has a market capitalization of $319 million, with net income of $35.3 million on revenue at $175 million in its most recent fiscal year.
Photo: Hi-Tech Pharmacal employees at work.